Company Filing History:
2 out of 15,475 
2 out of 505 
Years Active: 2007-2012
Title: Sandra Tobias: Innovator in Selective Estrogen Receptor Modulators
Introduction
Sandra Tobias is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of pharmacology, particularly in the development of selective estrogen receptor modulators (SERMs). With a total of 2 patents, her work has the potential to impact various therapeutic applications.
Latest Patents
Tobias's latest patents focus on the development of a new class of selective estrogen receptor modulators. The present disclosure concerns the identification of a previously unknown membrane-associated estrogen receptor. Additionally, the patents include methods for making and using these novel SERMs, along with pharmaceutical formulations that incorporate these innovative compounds.
Career Highlights
Throughout her career, Sandra Tobias has worked with esteemed institutions such as the University of California and Oregon Health & Science University. Her research has been pivotal in advancing the understanding of estrogen receptors and their role in various biological processes.
Collaborations
Some of her notable coworkers include Thomas S. Scanlan and Martin J. Kelly. Their collaborative efforts have contributed to the success of her research and the development of her patents.
Conclusion
Sandra Tobias is a trailblazer in the field of selective estrogen receptor modulators, with her innovative work paving the way for future advancements in pharmacology. Her contributions are invaluable to the scientific community and hold promise for therapeutic applications.